Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.
Funds from the fresh issue will be used for
The Company will utilize fresh issue proceeds to make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company, to finance capital expenditure requirements and to meet general corporate purposes.
Company Financials: (in crores)
How to apply for an IPO/Buyback Online via Navjeevan?
Step 1: Go to our website and select an IPO that you wish to apply for.
Step 2: Log in your details (Non-Navjeevan Client can log in via their mobile number).
Step 2: Enter the price at which you want to apply for shares and the number of lots and provide your UPI ID
Step 4: Submit the application and then approve the block funds request on the UPI App.